PNC Financial Services Group
NVCT icon

PNC Financial Services Group’s Nuvectis Pharma NVCT Stock Holding History

PNC Financial Services Group’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.22K Buy
58
+30
+107% +$633 ﹤0.01% 4958
2026
Q2 		$515 Buy
28
+5
+22% +$56 ﹤0.01% 4982
2026
Q1 		$178 Hold
23
– – ﹤0.01% 5045
2025
Q4 		$174 Sell
23
-32
-58% -$209 ﹤0.01% 4994
2025
Q3 		$331 Buy
+55
New +$378 ﹤0.01% 4874

Other funds holding NVCT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Iridian Asset Management
Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Baldwin Wealth Partners
Baldwin Wealth Partners Marion, Massachusetts $1.52B AUM 21.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Occam Crest Management
Occam Crest Management Darien, Connecticut $188M AUM 69.74% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

PNC Financial Services Group's NVCT Position: Q3 2026 in Review

PNC Financial Services Group increased its Nuvectis Pharma (NVCT) stake by 107% in Q3 2026, buying an estimated $633 and bringing the position to 58 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #4958.

PNC Financial Services Group first reported a position in NVCT in Q3 2025 and has held it in 5 quarters since. 65 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.

  • PNC Financial Services Group held 58 shares of Nuvectis Pharma worth $1.22K as of Q3 2026.
  • PNC Financial Services Group bought 30 Nuvectis Pharma shares in Q3 2026, an estimated $633.
  • Nuvectis Pharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4958 holding.
  • PNC Financial Services Group first reported a position in Nuvectis Pharma in Q3 2025 and has held it in 5 quarters since.
  • 65 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.